X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.430
+0.140 (3.26%)
At close: May 8, 2026, 4:00 PM EDT
4.350
-0.080 (-1.81%)
After-hours: May 8, 2026, 7:37 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $402.77 million as of May 8, 2026. Its market cap has increased by 1,052.16% in one year.
Market Cap
402.77M
Enterprise Value
246.31M
1-Year Change
1,052.16%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $402.77M, an increase of 295.76%. That is a compound annual growth rate of 21.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 390.05M | 11.52% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 394.62M |
| Invivyd | 393.10M |
| Niagen Bioscience | 386.79M |
| Rocket Pharmaceuticals | 386.48M |
| Monopar Therapeutics | 380.65M |
| Surrozen | 374.93M |
| Puma Biotechnology | 373.94M |
| Opus Genetics | 371.29M |